The earnings transcript for UnitedHealth Group Incorporated highlights several positive factors that are likely to have a favorable impact on the stock price in the short term:

1. **Strong Revenue and Earnings Growth**: UnitedHealth Group reported an 11.3% year-over-year revenue growth to $36.3 billion, with net earnings increasing by 15% to $1.64 per share. This broad-based growth across both UnitedHealthcare and Optum segments is a significant positive indicator[2][3].

2. **Improved Margins and Cost Management**: The company saw improvements in operating margins, particularly in Optum, and maintained steady margins in UnitedHealthcare. Medical cost trends were well-controlled, and the consolidated medical care ratio improved by 20 basis points year-over-year[2].

3. **Catamaran Merger**: The anticipated closing of the Catamaran transaction is expected to add significant revenue and contribute to future earnings growth, although the immediate impact on 2015 earnings is offset by integration costs[2][3].

4. **Dividend Increase and Strong Financial Position**: The company raised its dividend by 33% and plans to return nearly $2 billion to shareholders, indicating a strong financial position and commitment to shareholder value[2].

5. **Positive Outlook for 2016**: Management expressed confidence in continued growth and improved performance for 2016, driven by core business performance and strategic initiatives[2].

Given these positive factors, the stock is likely to see a short-term rally.

**Rating: 2**